HCA Holdings Inc (NYSE:HCA): Baird stated that HCA Holdings’ Q3 pre-announcement was disappointing, but it may be the best hospital quarter to be posted this season. The firm believes that there are muted trend numbers for the majority of providers and said that conversations with industry contacts suggests September was weaker than expected. Baird keeps its Outperform rating and a $39 price target on the stock.
Cree Inc. (NASDAQ:CREE) reported Q1 results seen by Oppenheimer as being strong, and the firm believes that the company continues to execute well. The firm keeps its Outperform rating.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Intel Corporation (NASDAQ:INTC) is expected by Cowen to return yesterday’s gains and to be range bound after its Q4 results due to a lack of visibility. The firm said the company’s dividend yield should provide support. Shares have an Outperform rating.
CSX Corp. (NYSE:CSX): According to Goldman, CSX reported satisfactory results, and it keeps its Buy rating due to its expectations that volumes will be boosted during Q1 2013 driven by organic growth and re-stocking.
EMC Corporation (NYSE:EMC) is expected by Goldman to be able to meet or beat Q3 expectations on October 24, possibly starting a relief rally in shares. According to the analyst, EMC’s competitive momentum and current product cycle enables it to outperform, and the firm would be aggressive buyers at current levels. Shares have a Buy rating and a $30 price target.